Association between obesity and Barrett's esophagus in a Japanese population: a hospital-based, cross-sectional study

• Published in: BMC gastroenterology Vol. 13; no. 1; p. 143
• Main Authors: Watari, Jiro, Hori, Kazutoshi, Toyoshima, Fumihiko, Kamiya, Noriko, Yamasaki, Takahisa, Okugawa, Takuya, Asano, Haruki, Li, Zhao Liang, Kondo, Takashi, Ikehara, Hisatomo, Sakurai, Jun, Tomita, Toshihiko, Oshima, Tadayuki, Fukui, Hirokazu, Miwa, Hiroto
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 26.09.2013; BioMed Central
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Analysis; Barrett Esophagus - epidemiology; Barrett's esophagus; Body Mass Index; Confidence intervals; Cross-Sectional Studies; Esophagitis, Peptic - epidemiology; Esophagoscopy; Female; Gastroenterology; Gastroesophageal reflux; Gastroesophageal Reflux - epidemiology; Humans; Japan - epidemiology; Logistic Models; Male; Medical research; Medicine; Medicine, Experimental; Middle Aged; Multivariate Analysis; Obesity; Obesity - epidemiology; Obesity, Abdominal - epidemiology; Odds Ratio; Population; Proton Pump Inhibitors - therapeutic use; Risk Factors; Sex Factors; Studies; Waist Circumference; Young Adult; Japan
• ISSN: 1471-230X; 1471-230X
• DOI: 10.1186/1471-230x-13-143

The association between obesity and Barrett's esophagus (BE) in the Japanese population remains unclear. The prevalence of BE and its associated risk factors was examined. A cross-sectional study of 1581 consecutive individuals who underwent upper gastrointestinal endoscopy was conducted. The prevalence of endoscopically suspected BE (ESBE) was evaluated. Obesity was evaluated by body mass index (BMI, ≥ 25 kg/m2) and waist circumference (WC) (males, ≥ 85 cm; females, ≥ 90 cm). Because endoscopic diagnosis of ultra-short ESBE (<1 cm in extent) is difficult and highly unreliable, this type of ESBE was excluded from the study. In proton pump inhibitor (PPI) non-users, the prevalence of ESBE ≥ 1 cm was 5.6%. In univariate analysis, male sex and reflux esophagitis (RE) were significantly associated with BE, but BMI, WC, and reflux symptoms were not. In multivariate logistic regression analysis, only RE (odds ratio [OR] = 3.48, 95% confidence interval [CI] 1.89-6.41, p < 0.0001) was an independent risk factor for BE; obesity and the other factors were not. In contrast, RE (OR 5.67, p = 0.0004) and large WC (OR 5.09, p = 0.0005) were significant risk factors for ESBE ≥ 1 cm in PPI users. Only male sex, but not obesity or the other risk factors, was associated with an increased risk of RE in patients not taking PPIs. RE, but not obesity, may have an independent association with the risk of ESBE in the Japanese population. Furthermore, obesity measures were not independent risks for RE. Interestingly, PPI-refractory RE and large WC were risk factors for ESBE ≥1 cm in patients taking PPIs.